Table 1.
Demographic and clinical characteristics of study participants by sex (N = 165)
| Women | Men | P | |
|---|---|---|---|
| (n = 53) | (n = 112) | ||
| Demography | |||
| Age, y ± SD | 61.2 ± 7.7 | 62.3 ± 8.7 | 0.42 |
| African-American, % | 29 (55) | 32 (29) | 0.001 |
| Education (high school) | 12 (23) | 33 (29) | 0.36 |
| Clinical Characteristics and Lifestyle Factors | |||
| BMI, ± SD | 31.2 ± 7.4 | 29.5 ± 5.2 | 0.09 |
| Current major depressive episode, SCID, % | 17 (32) | 24 (22) | 0.16 |
| Lifetime major depression, SCID, % | 31 (58) | 37 (33) | 0.002 |
| Abnormal angiogram | 37 (76) | 66 (60) | 0.06 |
| Abnormal nuclear test | 7 (14) | 14 (13) | 0.79 |
| Abnormal exercise test, % | 9 (18) | 13 (12) | 0.27 |
| Diabetes, % | 19 (36) | 38 (34) | 0.81 |
| Dyslipidemia, % | 40 (75) | 96 (86) | 0.11 |
| Heart Failure, % | 14 (26) | 12 (11) | 0.01 |
| Hypertension, % | 40 (75) | 85 (76) | 0.95 |
| MI History, % | 16 (30) | 47 (42) | 0.15 |
| MSI, % | 9 (17) | 35 (31) | 0.05 |
| Smoking History | |||
| Current Smoker, % | 7 (14) | 16 (15) | 0.31 |
| Former Smoker, % | 21 (43) | 60 (54) | |
| Never Smoker, % | 21 (38) | 34 (31) | |
| Medication Use | |||
| ACE Inhibitors, % | 21 (40) | 52 (47) | 0.38 |
| Antidepressants, % | 26 (50) | 29 (26) | 0.003 |
| Aspirin, % | 45 (85) | 96 (86) | 0.78 |
| Beta Blockers, % | 45 (85) | 77 (69) | 0.03 |
| Diuretics, % | 24 (45) | 26 (23) | 0.004 |
| Statins, % | 41 (84) | 99 (91) | 0.19 |
| Vasodilators, % | 5 (9) | 12 (11) | 0.79 |
Abbreviations: SPECT single photon emission computed tomography, MSI mental stress ischemia, BMI body mass index, SCID Structured Clinical Interview for DSM IV, MI myocardial infarction